Related Experiment Video
Updated: Jun 2, 2025
07:56
Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models
Published on: November 11, 2020
4.2K
[Pneumology : what's new in 2024]
Frédéric Lador1, Pieter-Jan Gijs2, Léon Genecand3
1Faculté de médecine, Université de Genève, 1205 Genève.
Revue Medicale Suisse
|January 15, 2025
Summary
2024 innovations advance respiratory disease management, including pulmonary hypertension, COPD, and tuberculosis treatments. New therapies offer personalized medicine and improved patient outcomes.
Area of Science:
- Respiratory Medicine
- Pulmonology
- Medical Innovations
Context:
- Management of chronic respiratory diseases like pulmonary hypertension, COPD, and tuberculosis.
- Emerging trends in personalized medicine for respiratory conditions.
Purpose:
- To highlight key 2024 innovations in respiratory disease management.
- To discuss advancements in pulmonary hypertension, COPD, and tuberculosis treatment.
Summary:
- Introduction of sotatercept for pulmonary arterial hypertension and mediastinal cryobiopsies in Switzerland.
- Development of biologic therapies for COPD and potential for shortened tuberculosis treatment regimens.
- Focus on personalized medicine approaches and novel therapeutic options.
Impact:
- Potential for enhanced patient care and significant clinical benefits.
- Opening new avenues for treating complex respiratory conditions.
- Shifting towards more tailored and effective treatment strategies.
Related Concept Videos
01:30Pneumonia III: Complications and Assessment
153
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
153
01:28Pneumonia IV: Management
297
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
297
01:30Pneumonia V: Nursing management and Prevention
1.8K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
1.8K
01:30Pneumonia I: Introduction
205
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
205
01:27Pneumothorax-II
120
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
120
01:29Pneumonia II: Pathophysiology
212
The pathophysiology of pneumonia involves the following steps:
212